ESR1 and breast carcinoma: A related finding was also reported in the Chicago Breast Cancer cohort, where no association was reported between level of arsenic exposure measured 3–6 years prior to breast cancer diagnosis, and odds of having an ER or PR negative breast cancer (ORER/PR negative breast cancers = 0.8; 95%CI 0.5–1.5) [66].